These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2512404)

  • 21. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
    Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological modulation of antigen-induced airway hyperresponsiveness by thromboxane A2 inhibitors in guinea pigs.
    Nagai H; Tsuji F; Goto S; Koda A
    Biol Pharm Bull; 1993 Nov; 16(11):1099-103. PubMed ID: 8312863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.
    Hatziantoniou C; Papanikolaou N
    Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats.
    Kobayashi T; Esato K; Morita N; Noshima NS
    Int Surg; 1996; 81(2):115-8. PubMed ID: 8912073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic thromboxane inhibition preserves function of rejecting rat renal allografts.
    Coffman TM; Ruiz P; Sanfilippo F; Klotman PE
    Kidney Int; 1989 Jan; 35(1):24-30. PubMed ID: 2651752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046].
    Ohsugi S
    Nihon Geka Hokan; 1986 Mar; 55(2):297-305. PubMed ID: 3827476
    [No Abstract]   [Full Text] [Related]  

  • 27. Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart.
    Ito T; Toki Y; Hieda N; Okumura K; Hashimoto H; Ogawa K; Satake T
    Jpn Circ J; 1989 Sep; 53(9):1115-21. PubMed ID: 2513429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of thromboxane A2 synthetase inhibitor on immediate-type hypersensitivity reactions.
    Nakagawa T; Miyamoto T; Urata C; Mano K; Yukawa T; Makino S
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):539-40. PubMed ID: 2437053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ONO-3122 (an enhancer of PGH2 production) and OKY-1581 (an inhibitor of TXA2 production) on the vasopressin-induced water flow in the toad bladder.
    Marumo F
    Pharmacology; 1985; 31(1):34-9. PubMed ID: 3927326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction by prostacyclin of acetaminophen-induced liver toxicity in the mouse.
    Guarner F; Boughton-Smith NK; Blackwell GJ; Moncada S
    Hepatology; 1988; 8(2):248-53. PubMed ID: 3281885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
    Niwa T; Nomura T; Ozawa Y; Maeda K; Shibata M
    Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):655-65. PubMed ID: 3682335
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T; Maeda K; Shibata M; Yamada K
    Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel prostaglandin I2 mimetic ONO-1301 escapes desensitization in an antiplatelet effect due to its inhibitory action on thromboxane A2 synthesis in mice.
    Kashiwagi H; Yuhki K; Kojima F; Kumei S; Takahata O; Sakai Y; Narumiya S; Ushikubi F
    J Pharmacol Exp Ther; 2015 May; 353(2):269-78. PubMed ID: 25740898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of TXA synthesis with OKY-046 improves liver preservation by prolonged hypothermic machine perfusion in rats.
    Xu H; Lee CY; Clemens MG; Zhang JX
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e212-20. PubMed ID: 17645480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory action of OKY-O46.HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness of guinea pigs: role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness.
    Takehana Y; Hamano S; Kikuchi S; Komatsu H; Okegawa T; Ikeda S
    Jpn J Pharmacol; 1990 Apr; 52(4):621-30. PubMed ID: 2160552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prostacyclin agonist with thromboxane inhibitory activity for airway allergic inflammation in mice.
    Hayashi M; Koya T; Kawakami H; Sakagami T; Hasegawa T; Kagamu H; Takada T; Sakai Y; Suzuki E; Gelfand EW; Gejyo F
    Clin Exp Allergy; 2010 Feb; 40(2):317-26. PubMed ID: 20015276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs.
    Chung KF; Aizawa H; Becker AB; Frick O; Gold WM; Nadel JA
    Am Rev Respir Dis; 1986 Aug; 134(2):258-61. PubMed ID: 3509981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of thromboxane A2-synthetase inhibitor OKY-046 and evening primrose oil (Efamol) on mercuric chloride induced autoimmune glomerulonephritis in Brown-Norway rats.
    Papanikolaou N; Hatziantoniou C; Gkika EL
    Prog Clin Biol Res; 1987; 242():43-9. PubMed ID: 3671393
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites.
    Gentilini P; Laffi G; Meacci E; La Villa G; Cominelli F; Pinzani M; Buzzelli G
    Gastroenterology; 1988 Jun; 94(6):1470-7. PubMed ID: 3360268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.